Jukema, J. B., Kusters, C. H. J., Jong, M. R., Fockens, K. N., Boers, T., van der Putten, J. A., Pouw, R. E., Duits, L. C., Weusten, B. L. A. M., Herrero, L. A., Houben, M. H. M. G., Nagengast, W. B., Westerhof, J., Alkhalaf, A., Mallant-Hent, R., Scholten, P., Ragunath, K., Seewald, S., Elbe, P., … Wolfsen, H. C. (2024). Computer-aided diagnosis improves characterization of Barrett’s neoplasia by general endoscopists (with video). Gastrointestinal Endoscopy, 100(4), 616-625.e8. https://doi.org/10.1016/j.gie.2024.04.013

Solfisburg, Q. S., Baldini, F., Baldwin-Hunter, B., Austin, G. I., Lee, H. H., Park, H., Freedberg, D. E., Lightdale, C. J., Korem, T., & Abrams, J. A. (2023). The Salivary Microbiome and Predicted Metabolite Production Are Associated with Barrett’s Esophagus and High-Grade Dysplasia or Adenocarcinoma. Cancer Epidemiology, Biomarkers & Prevention, 33(3), 371–380. https://doi.org/10.1158/1055-9965.epi-23-0652

Iyer, P. G., Slettedahl, S. W., Mahoney, D. W., Giakoumopoulos, M., Olson, M. C., Krockenberger, M., Taylor, W. R., Foote, P., Berger, C., Leggett, C., Wu, T.-T., Antpack, E., Falk, G. W., Ginsberg, G. G., Abrams, J. A., Lightdale, C. J., Ramirez, F., Kahn, A., Wolfsen, H., … Kisiel, J. B. (2024). Algorithm Training and Testing for a Nonendoscopic Barrett’s Esophagus Detection Test in Prospective Multicenter Cohorts. Clinical Gastroenterology and Hepatology, 22(8), 1596-1604.e4. https://doi.org/10.1016/j.cgh.2024.03.003

Sun, J., Sepulveda, J. L., Komissarova, E. V., Hills, C., Seckar, T. D., LeFevre, N. M., Simonyan, H., Young, C., Su, G., Del Portillo, A., Wang, T. C., & Sepulveda, A. R. (2024). CDKN2A-p16 Deletion and Activated KRASG12D Drive Barrett’s-Like Gland Hyperplasia-Metaplasia and Synergize in the Development of Dysplasia Precancer Lesions. Cellular and Molecular Gastroenterology and Hepatology, 17(5), 769–784. https://doi.org/10.1016/j.jcmgh.2024.01.014

Muthupalani, S., Annamalai, D., Feng, Y., Ganesan, S. M., Ge, Z., Whary, M. T., Nakagawa, H., Rustgi, A. K., Wang, T. C., & Fox, J. G. (2023). IL-1β transgenic mouse model of inflammation driven esophageal and oral squamous cell carcinoma. Scientific Reports, 13(1). https://doi.org/10.1038/s41598-023-39907-8

Crowe, B. R., Krigel, A., Li, T., Haile, R., Al-Ani, F., Lebwohl, B., Abrams, J. A., & Araujo, J. L. (2023). Veterans with multiple risk factors for Barrett’s esophagus are infrequently evaluated with upper endoscopy. Diseases of the Esophagus, 36(9). https://doi.org/10.1093/dote/doad007

Rubenstein, J. H., Burns, J. A., Arasim, M. E., Firsht, E. M., Harbrecht, M., Widerquist, M., Evans, R. R., Inadomi, J. M., Chang, J. W., Hazelton, W. D., Hur, C., Kurlander, J. E., Lim, F., Luebeck, G., Macdonald, P. W., Reddy, C. A., Saini, S. D., Tan, S. X., Waljee, A. K., & Lansdorp-Vogelaar, I. (2023). Yield of Repeat Endoscopy for Barrett’s Esophagus After Normal Index Endoscopy. American Journal of Gastroenterology, 118(7), 1168–1174. https://doi.org/10.14309/ajg.0000000000002204

Quante, M., Wang, T. C., & Bass, A. J. (2022). Adenocarcinoma of the oesophagus: is it gastric cancer? Gut, 72(6), 1027–1029. https://doi.org/10.1136/gutjnl-2022-327096

Chen, L., Lu, H., Peng, D., Cao, L. L., Ballout, F., Srirmajayam, K., Chen, Z., Bhat, A., Wang, T. C., Capobianco, A., Que, J., McDonald, O. G., Zaika, A., Zhang, S., & El-Rifai, W. (2022). Activation of NOTCH signaling via DLL1 is mediated by APE1-redox-dependent NF-κB activation in oesophageal adenocarcinoma. Gut, 72(3), 421–432. https://doi.org/10.1136/gutjnl-2022-327076

Ballout, F., Lu, H., Chen, L., Sriramajayam, K., Que, J., Meng, Z., Wang, T. C., Giordano, S., Zaika, A., McDonald, O., Peng, D., & El-Rifai, W. (2022). APE1 redox function is required for activation of Yes-associated protein 1 under reflux conditions in Barrett’s-associated esophageal adenocarcinomas. Journal of Experimental & Clinical Cancer Research, 41(1). https://doi.org/10.1186/s13046-022-02472-5

Rubenstein, J. H., Omidvari, A.-H., Lauren, B. N., Hazelton, W. D., Lim, F., Tan, S. X., Kong, C. Y., Lee, M., Ali, A., Hur, C., Inadomi, J. M., Luebeck, G., & Lansdorp-Vogelaar, I. (2022). Endoscopic Screening Program for Control of Esophageal Adenocarcinoma in Varied Populations: A Comparative Cost-Effectiveness Analysis. Gastroenterology, 163(1), 163–173. https://doi.org/10.1053/j.gastro.2022.03.037

Fang, H.-Y., Stangl, S., Marcazzan, S., Carvalho, M. J. B., Baumeister, T., Anand, A., Strangmann, J., Huspenina, J. S., Wang, T. C., Schmid, R. M., Feith, M., Friess, H., Ntziachristos, V., Multhoff, G., Gorpas, D., & Quante, M. (2021). Targeted Hsp70 fluorescence molecular endoscopy detects dysplasia in Barrett’s esophagus. European Journal of Nuclear Medicine and Molecular Imaging, 49(6), 2049–2063. https://doi.org/10.1007/s00259-021-05582-y

Genere, J. R., Visrodia, K., Zakko, L., Hoefnagel, S. J. M., & Wang, K. K. (2022). Spray cryotherapy versus continued radiofrequency ablation in persistent Barrett’s esophagus. Diseases of the Esophagus, 35(5). https://doi.org/10.1093/dote/doab084

Ekheden, I., Ludvigsson, J. F., Yin, L., Elbe, P., & Ye, W. (2022). Esophageal abnormalities and the risk for gastroesophageal cancers—a histopathology-register-based study in Sweden. European Journal of Epidemiology, 37(4), 401–411. https://doi.org/10.1007/s10654-021-00833-6

Sahm, V., Maurer, C., Baumeister, T., Anand, A., Strangmann, J., Schmid, R. M., Wang, T. C., & Quante, M. (2022). Telomere shortening accelerates tumor initiation in the L2-IL1B mouse model of Barrett esophagus and emerges as a possible biomarker. Oncotarget, 13(1), 347–359. https://doi.org/10.18632/oncotarget.28198